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The colorless carotenoids phytoene and phytofluene are comparatively understudied compounds found in common foods (e.g.,
tomatoes) and in human plasma, internal tissues, and skin. Being naturally present in common foods, their intake at dietary levels
is not expected to present a safety concern. However, since the interest in these compounds in the context of many applications
is expanding, it is important to conduct studies aimed at assessing their safety. We present here results of in vitro cytotoxicity
and genotoxicity studies, revealing no significant cytotoxic or genotoxic potential and of short- and long-term human in vivo skin
compatibility studies with phytoene- and phytofluene-rich tomato andDunaliella salina alga extracts, showing a lack of irritancy or
sensitization reactions.These results support the safe use of phytoene- and phytofluene-rich products in human topical applications.
1. Introduction
Dietary carotenoids are important compounds in the context
of food science, nutrition, and health as they account for the
color of many foods, some can be converted into compounds
exhibiting vitamin A activity, and there is a large body of
evidence indicating that they may exert health-promoting
actions and contribute to reducing the risk of developing
several diseases [1, 2]. Their value as food colorants, com-
ponents of functional foods, and related products such as
dietary supplements and other over-the-counter healthcare
products is therefore undeniable. There is also an expanding
interest in these compounds in the context of nutricosmetics,
a growing sector that includes products at the intersection
between food, nutrition, health, and cosmetics. These can
promote “beauty from within” and are usually referred to
as “beauty foods,” “beauty pills,” or “oral cosmetics” [3, 4].
Similarly, carotenoids have a long history of use in topical
cosmetic formulations, aimed at delivering diverse beauty
and personal care benefits like antiaging, anti-inflammation,
antioxidation, and more [5–7].
Historically, the most studied carotenoids (and those
most often used in carotenoid-linked health- and food-
related claims) have been colored carotenoids such as
lycopene, 𝛽-carotene, astaxanthin, or lutein. A relatively wide
array of safety data is available regarding each of these
compounds, as will be discussed later.
This is not the case for phytoene and phytofluene, which
are considered the precursors of all colored carotenoids
[8] and are rarities among carotenoids as they are color-
less. This can explain in part the fact that phytoene and
phytofluene have not been studied as intensively as other
dietary carotenoids despite being present inwidely consumed
foods (tomatoes, citrus, carrots, among others) [9]. Besides,
phytoene and phytofluene have been shown to be efficiently
released from diverse food matrices using simulated in
vitro digestions [10]; phytoene and phytofluene are present
in human plasma, internal tissues, and skin [11–14]; and,
more importantly, there are studies pointing to the fact
that phytoene and phytofluene may be involved in diverse
health-promoting actions. More specifically, phytoene and
phytofluene could participate in antioxidant [15, 16] and
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anti-inflammatory actions [17, 18], decrease DNA damage in
lymphocytes [19], and protect against skin and other types of
cancer (leukemia, breast, endometrium, and prostate) [20–
24] and against light-induced erythema in the skin [25].
Interestingly, these colorless carotenoids could also partici-
pate in biological actions leading to cosmetic benefits. Thus,
it has been recently reported that a 12-week intervention
with a freeze-dried natural tomato powder food supplement
(Israeli Biotechnology Research Ltd. (IBR), Yavne, Israel) led
to improvements in a series of skin quality parameters (skin
radiance, suppleness, evenness, smoothness, moisturization,
elasticity, visible skin health, visible skin youthfulness, and
overall skin beauty) that were both clinically assessed and
self-perceived by the volunteers [25]. The growing impor-
tance of the scarcely studied carotenoids phytoene and
phytofluene across several research fields has been the subject
of a dedicated comprehensive review [26].
Being naturally present in a variety of common and
exotic dietary sources [26] their intake at dietary levels is not
expected to pose important safety concerns. However, since
their interest in the context of the diet, functional foods, and
nutricosmetics is expected to expand considerably in the near
future; and, considering the relative scarcity of data on this
matter, it is important to conduct studies aimed at assessing
their safety.
Following the above, we thus present herein results of
several in vitro and topical in vivo human toxicological stud-
ies with additional phytoene- and phytofluene-rich liquid
extracts from tomato and algal sources.
2. Materials and Methods
2.1. In Vitro Toxicology: Cytotoxicity by Neutral Red
Release (NRR) Protocol
2.1.1. Phytoene- and Phytofluene-Rich Products Tested. Tested
substances (Israeli Biotechnology Research Ltd. (IBR), Yavne,
Israel) consisted of phytoene- and phytofluene-rich botanical
extracts in oil carriers: (1) a tomato extract in squalene oil,
containing ca. 0.75mg/mL phytoene and phytofluene, and
(2) an extract of Dunaliella salina alga in hydrogenated poly-
decene oil, containing ca. 1mg/mL phytoene and phytofluene
(both by UV spectrophotometry). Paraffin oil (aka mineral
oil, Fluka) was used as negative control, as well as to dilute
tested substances. An SDS solution (0.01, 0.05, and 0.20%)
served as positive control.
2.1.2. Experimental Conditions. Themethodology was adapt-
ed from that described elsewhere [27]. The tested sub-
stances above were diluted and applied to a monolayer
of rabbit cornea fibroblasts (SIRC #2-552, CCL60; ATCC,
Virginia USA) marked with a vital dye (Neutral Red). The
cells were cultured in complete DMEM medium supple-
mented with decomplemented fetal calf serum and a peni-
cillin/streptomycin solution, at 37∘C under 5% CO2. Cells
were seeded and incubated for 24 h, the culture medium was
removed, andNeutral Red coloring solution was added. After
3 h further incubation, the coloring solution was removed
and replaced by complete culture medium. The cells were
Table 1: Classification of cytotoxicity results in the NRR method.
IC50 (%) % cell death at the 50%dilution Classification
>50 <20 Negligible cytotoxicity
>20 Low cytotoxicity
>25 and <50 Moderate cytotoxicity
<25 High cytotoxicity
then maintained at room temperature for 30min, following
which the wells were washed with PBS and treated with
the diluted test products. Following 60 seconds’ contact, the
wells were washed with PBS. Acetic acid (in ethanol) was
added, and after 15min agitation the revealed solutions were
transferred to 96-well plates (in duplicate) and optical density
was read (Multiskan RC ascent 2.6 reader).The percentage of
cell death was calculated as follows: % cell death = 100 × (OD
of treated wells/OD of control wells). The tested substances
were tested in dilutions at 5, 15, 25, 35, and 50%. The IC50 of
each test item was then calculated by linear regression.
The results are then classified as described in Table 1.
2.2. In Vitro Toxicology: Genotoxic Potential
2.2.1. Phytoene- and Phytofluene-Rich Products Tested. The
tested substance consisted of a hydrophobic phytoene- and
phytofluene-richDunaliella salina extract (Israeli Biotechnol-
ogy Research Ltd. (IBR), Yavne, Israel) in hexane, which was
evaporated and then taken up in a like volume of ethanol and
diluted 1/10 to 1/10000 with ultrapure water.
2.2.2. Experimental Conditions. The test method is part of a
cell-free in vitro reconstitution of the repair process of DNA
damage generated by Reactive Oxygen Species (ROS) [28],
where highly purified plasmidDNA adsorbed onto sensitized
wells were exposed for 30min to the potential genotoxic
agent and then repaired by exposure over 3 h to repair
enzymes and dUTP-biotin, resulting in the incorporation
of biotin moieties. These were then tagged by 15-minute
exposure to streptavidin and a chemiluminescent peroxidase
substrate (5min), and the luminescence was quantified with
a luminometer (SFRI Lumax 2).
The genotoxicity of the sample was evaluated according
to the quantity of repairs thus detected (directly related to
the amount of damage caused), as expressed by the ratio
of luminescence obtained with the test sample to that of
the solvent control. A repair ratio greater than 2 would
indicate significant genotoxicity, while a ratio of less than 2
would indicate no significant genotoxicity. Methyl methane-
sulfonate (MMS) was used as a positive control.
2.3. Topical Toxicology In Vivo (Human): 48 h Patch Testing
2.3.1. Phytoene- and Phytofluene-Rich Products Tested. The
tested substances consisted of a phytoene- and phytofluene-
rich tomato extract in hydrogenated polydecene or squalane
oil carriers (Israeli Biotechnology Research Ltd. (IBR),
Yavne, Israel), each containing ca. 0.75mg/mL phytoene and
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phytofluene (by UV spectrophotometry), and a phytoene-
and phytofluene-rich Dunaliella salina extract in hydro-
genated polydecene oil, containing ca. 1.0mg/mL phytoene
and phytofluene (by UV spectrophotometry).
2.3.2. Experimental Conditions. The test method aims at
evaluating the skin compatibility of the tested products,
after a single skin application under controlled maximizing
experimental conditions [29]. Each study included 10-11
subjects (subjects were healthy; male and female; 18–70 years
old; all skin types; Fitzpatrick phototypes I–V). Single patch
applications of the testmaterial (applied neat, without further
dilution) were made on the subjects’ back, under occlusive
patches (Finn Chamber, Epitest Ltd.; Trumed; or IQ Ultra),
for 48 h. Distilled water was applied under a control patch.
2.3.3. Examinations and Observations. Skin compatibility of
the tested substances was evaluated visually 15–30 minutes
after patch removal, based on skin examination of the treated
and control areas and reporting of any sensations of discom-
fort by the test subjects. Observed erythema was graded on
a 5-point scale from “no visible erythema” to “caustic effect-
erosive and/or necrotic aspect.” Skin irritation was graded
according to the International Contact Dermatitis Research
Group scale (from “no reaction” to “extreme positive reac-
tion”). The appearance of other signs of cutaneous reaction
was also recorded, including infiltration/edema, papules,
vesicles, bulla, petechiae, fissures, desquamation, dryness,
hyper- or hypopigmentation, follicular reactions, exudation
and/or surface encrustation, scabs, itching, heating, burning,
and any extension of reactions beyond the area of the patch.
Finally, observations were collected from study participants,
and any other adverse events were recorded. An individual
daily irritation score (IDIS) was calculated as follows: IDIS
= sum of the grades obtained for visible clinical signs
observed on the application area. Additionally a mean daily
irritation score (MDIS) is calculated as follows: MDIS =
∑(IDIS)/number of valid cases.
2.4. Topical Toxicology In Vivo (Human): Repeat Insult
Patch Testing (HRIPT)
2.4.1. Phytoene- and Phytofluene-Rich Products Tested. The
tested substances consisted of a phytoene- and phytofluene-
rich Dunaliella salina extract in hydrogenated polydecene
oil, containing ca. 0.02mg/mL phytoene and phytofluene
(by UV spectrophotometry), and of a phytoene- and
phytofluene-rich tomato fruit extract in squalane, containing
ca. 0.75mg/mL phytoene and phytofluene (by UV spec-
trophotometry) (Israeli Biotechnology Research Ltd. (IBR),
Yavne, Israel).
2.4.2. Experimental Conditions. The studies were performed
on 50 subjects each (subjects were healthy; male and female;
18–70 years old; all skin types; Fitzpatrick phototypes I–V).
The test method used was the widely recognized protocol
described by Marzulli and Maibach [30]. During the first
phase (induction phase), nine patch applications of 20𝜇L
of the test material (applied neat, without further dilution)
Table 2: Genotoxicity results.










were made under occlusive Finn Chamber patches (Epitest
Ltd.), on the same skin site on the subjects’ back, over a
3-week period. Each application lasted for 48 to 72 h. Skin
reactions were scored 15–30 minutes after removal of each
patch application, following which a new patch application is
performed. The induction phase was followed by a 2–4 week
rest phase, after which a single 48 h application (challenge
phase) was carried out under the same conditions as above,
both on the same skin site as used in the induction phase
and on a corresponding fresh skin site on the opposite side of
the subjects’ back. Scoring of skin reactions was performed
30 minutes, and once more 48 hours, after removal of the
challenge patch.
2.4.3. Examinations and Observations. The scoring of skin
reactions was performed as follows: intensity of erythema
and edema was assessed on an ordinal scale from “none” to
“severe”; the appearance of main signs of cutaneous reaction
was noted, such as erythema, edema, papules, vesicles, bulla,
scabs, petechiae, fissures, desquamation, dryness, hyper-
or hypopigmentation or other discoloration, and follicular
reactions. A grade was either assigned according to the Inter-
national Contact Dermatitis Research Group (ICDRG) scale
or calculated based on observed signs (mean daily irritation
score =∑[individual daily irritation scores]/number of sub-
jects, where individual daily irritation scores were calculated
based on grading of each observed sign of reaction).
3. Results
3.1. In Vitro Toxicology: Cytotoxicity by Neutral Red Release
(NRR) Protocol. In the NRR protocol, both the tomato
extract and the Dunaliella salina extract were classified as
having negligible cytotoxicity, upon exhibiting an LD50 of
over 50%, and less than 20% cell death at the 20% dilution.
3.2. In Vitro Toxicology: Genotoxic Potential. The results of
the test are summarized in Table 2.
According to the results shown in Table 2, the tested
sample may be classified as having no genotoxic potential up
to a 1/10 dilution.
3.3. Topical Toxicology In Vivo (Human): 48 h Patch Testing.
The results of the studies described in Section 2.3 are sum-
marized in Table 3.
Based on the observations made during the 48 h Patch
Testing, the phytoene- and phytofluene-rich extracts tested
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Table 3: 48 h patch test results.
Test substance Tomato extract in squalane Tomato extract inhydrogenated polydecene
Dunaliella extract in
hydrogenated polydecene
Reactions noted None None None
# reactive subjects (%) 0 (0%) 0 (0%) 0 (0%)
MDIS 0 0 0





may be classified as nonirritant and having very good skin
compatibility.
3.4. Topical Toxicology In Vivo (Human): Repeat Insult Patch
Testing (HRIPT). During the induction phase, no clinically
significant objective signs of skin reaction were noted in any
subjects with either product tested.
With the Dunaliella extract, the average erythema grade
was 1 (slight erythema only). During the challenge phase,
once again no clinically significant objective signs of skin
reaction were noted in any subjects (ICDRG grade = 0, no
reaction). Overall irritation grades were recorded as 0.00 for
both the induction and the challenge phase. No significant
clinical adverse event was noted during the study.
With the tomato extract, the mean daily irritation score
was 0 at every testing point in the study.
Therefore, it may be concluded that the tested extracts did
not induce any sensitization or allergic reactions and are very
well tolerated on human skin.
4. Discussion
The different pieces of experimental evidence presented
in this paper point to the fact that the use of colorless
carotenoids phytoene and phytofluene in topical formula-
tions does not pose important safety concerns. Apart from
this, there are other pieces of evidence indicating that these
compounds are part of the common diets ofmany ethnicities,
that they are present in human fluids and tissues, and that
they may even provide health and cosmetic benefits, as sum-
marized in the introduction. In relation to the presumable
safety of phytoene and phytofluene it is to be noted that there
is ample evidence concerning the safety of the other major
carotenoids found in humans and in amounts much higher
than those commonly achievable through the diet.
4.1. Dietary Sources of Phytoene and Phytofluene. Almost
without exception, phytoene and phytofluene levels in foods
have not been included in food composition tables or
databases [31–36] or in dedicated studies [9, 37, 38]. However,
this situation is expected to change in the near future as
evidence is accumulating that phytoene and phytofluene can
provide health benefits [26, 39], which is expected to lead to
heightened interest in these compounds.
However, phytoene and phytofluene can be found in
common foods in Western diets like apricot, cantaloupe,
banana, carrot, melon, oranges, peppers, watermelon, lemon,
clementines, grapefruits, avocado, mandarin, nectarine,
peach, and a wide variety of tomatoes and derivatives
(reviewed in [26]) and in other more exotic and highly
nondomesticated foods. Examples of the latter would be
caja [40], buriti, mamey, marimari, physalis [41], or gac
[42], among others. It is noteworthy that phytoene and
phytofluene are also found in ancient Andean wild relatives
of the domesticated tomato [43].Thus, it can be inferred that
phytoene and phytofluene are common in the diet of humans
from different geographical regions and ethnicities and that
it is sensible to think that they have been part of their diet for
centuries if not millennia.
4.2. Phytoene and Phytofluene Intakes. The carotenoid
intakes reported in different countries are summarized in
Table 4.
Phytoene and phytofluene have not been taken into
account in most dietary intake studies. Recently, these were
estimated to be 2.0mg and 0.7mg, respectively, in Luxem-
bourg [6]. The fact that the intakes of phytoene were second
only to 𝛼- + 𝛽-carotene and that these intakes were higher
than those of lycopene (1.8mg) is noteworthy. Higher intakes
of phytoene relative to lycopenemay also be expected in other
countries. Phytoene and phytofluene typically accompany
lycopene in the dietary sources of the latter (e.g., tomato and
derivatives, watermelons, and red-fleshed citrus), although
their levels are normally considerably lower [9, 44–47].
However, the distribution of the colorless carotenoids among
dietary sources seems to be broader as these compounds are
also found in widely consumed fruits and vegetables that do
not contain detectable levels of lycopene, like most carrots,
peaches, nectarines, red peppers, oranges, and other citrus
varieties [26].
4.3. Safety of Dietary Carotenoids. Being naturally biosynthe-
sized by all plants, it can be claimed that carotenoids have
always been present in the diet of the human species. Thus,
all green leaves and other plant photosynthetic tissues contain
high amounts of lutein and the provitaminA𝛽-carotene [48],
two carotenoids bioavailable in humans that are thought to
provide health benefits [2, 49]. Likewise, other plant foods
(roots, fruits, and seeds) provide other health-promoting
carotenoids like lycopene, 𝛽-cryptoxanthin, zeaxanthin, phy-
toene, and phytofluene [26, 39, 50–55]. Interestingly, the
first natural food of newborns, their mothers’ milk, contains
carotenoids, including phytoene and phytofluene, with high
levels of lutein, which is thought to be important for their
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Table 4: Reported carotenoid intakes (mg/day) in different countries. Adapted fromMaiani et al. (2009) and Biehler et al. (2012).
Country TI∗ L + Z BCR LYC ACA BCA PT PTF
Germany 9.37 4.87 0.28 0.75 0.28 3.09 n.r. n.r.
Denmark 10.10 5.25 0.40 0.71 0.30 3.43 n.r. n.r.
Italy 15.73 7.09 0.63 2.36 0.47 5.20 n.r. n.r.
Sweden 7.52 3.61 0.38 0.83 0.23 2.41 n.r. n.r.
UK 8.65 4.33 0.35 0.78 0.26 2.86 n.r. n.r.
Greece 20.97 8.39 0.63 4.40 0.84 6.71 n.r. n.r.
France 13.98 6.99 0.56 1.26 0.42 4.75 n.r. n.r.
Netherlands 8.76 4.21 0.44 0.88 0.26 2.89 n.r. n.r.
Spain 12.79 5.76 0.51 1.79 0.38 4.35 n.r. n.r.
Luxembourg 15.30 1.80 1.40 1.80 7.60∗∗ 2.00 0.70
L: lutein; Z: zeaxanthin; BCR: 𝛽-cryptoxanthin; LYC: lycopene; ACA: 𝛼-carotene; BCA: 𝛽-carotene; PT: phytoene; PTF: phytofluene; n.r.: not reported; ∗total
Intake (TI): sum of the individual values of L + Z, BCR, LYC, ACA, and BCA (and also of the levels of PT and PTF in the case of Luxembourg); ∗∗sum of the
intakes of ACA + BCA.
development [49, 56]. Phytoene and phytofluene have also
been reported in plasma at concentrationswithin the range 0-
1 𝜇M [11, 19, 57–60] and in several human tissues (liver, lung,
breast, cervix, prostate, colon, and skin) at levels in the range
of ng/g [13]. Taking all these facts into consideration it can be
presumed that carotenoids at dietary levels are safe and that
these compounds could even provide diverse health benefits.
4.3.1. Safety Data of Other Major Dietary Carotenoids. There
is ample evidence that 𝛽-carotene from diverse sources
(synthetic, plants, algae, and fungi) is a safe compound. LD50
values up to over 20000mg/kg and No-Observed-Adverse-
Effect Level (NOAEL) from 696 up to 4175mg/kg body
weight/day have been reported. The EFSA Panel on Food
Additives andNutrient Sources added to food stated that “the
use of 𝛽-carotene [E 160a (ii)] as food color [is] not of safety
concern, provided that the estimated combined intake from
their use as a food additive and as food supplement, is not
more than the amount likely to be ingested as a result of
the regular consumption of the foods in which they occur
naturally (5–10mg/day).” [61].
Values of LD50 over 2000mg/kg and NOAEL between
200 and 1000mg/kg body weight/day have been reported
for lutein. Moreover, the EFSA Panel on Food Additives
and Nutrient Sources added to Food established an ADI of
1mg/kg body weight/day [62]. Several lutein products have
been categorized as GRAS by the FDA [63–68].
Values of LD50 over 3000mg/kg body weight and of
NOAEL ranging from 50 to 600mg/kg body weight/day have
been reported for lycopene. The Panel on Food Additives,
Flavorings, Processing Aids, and Materials in Contact with
Food derived an ADI of 0.5mg/kg body weight/day for
lycopene from all sources. The panel also stated that the
ADI applies to lycopene from tomatoes, [69]. The EFSA
Panel on Dietetic Products, Nutrition and Allergies also
provided an opinion on the safety of a lycopene oleoresin
from non-GM high-lycopene tomatoes. This product con-
tained 5–15% lycopene, phytoene (0.5–0.75%), phytofluene
(0.4–0.65%), and 𝛽-carotene (0.2–0.35%), as well as other
lipophilic compounds, including tocopherols (1.5–3%). The
panel stated that the lycopene oleoresin was as safe as
lycopene from other accepted sources [70]. Several lycopene
or lycopene-rich products have been categorized as GRAS by
the FDA, including synthetic lycopene [71], tomato lycopene
[71], tomato pulp powder [72], concentrated tomato lycopene
extract [73], and even lycopene produced by Escherichia coli
expressing lycopene biosynthetic enzymes [74].
Values of LD50 over 8000mg/kg [75] and NOAEL of
150mg/kg body weight per day have been reported for
synthetic zeaxanthin. The EFSA Panel on Dietetic Products,
Nutrition and Allergies has concluded that daily intakes of
0.75mg/kg body weight do not raise safety concerns [76].
Several zeaxanthin products have been categorized as GRAS
by the FDA, including zeaxanthin from Capsicum annuum
[77] and marigold (Tagetes erecta) [78].
5. Conclusions
Carotenoids are natural compounds widespread in foods that
are naturally present in the diet and can be used as additives
or ingredients of supplements. They are present in human
plasma and tissues. There is ample toxicological evidence
concerning their safety, and indeed there are carotenoids or
carotenoid-containing products categorized as GRAS by the
US FDA. On the other hand, EFSA has established ADIs of
0.5 and 1mg/kg body weight/day for the common dietary
carotenoids lycopene and lutein, respectively.Thismeans that
daily intakes of 30 and 60mg of such carotenoids by a person
of 60 kg are not considered of safety concern. These intakes
are considerable higher than the daily total dietary carotenoid
intakes assessed in several countries (ranging from ca. 7.5 to
21mg/day, Table 2).
The colorless carotenoids phytoene and phytofluene are
present in widely consumed foods (like tomatoes, citrus, or
carrots among many others) as well as in human plasma,
milk, internal tissues, and skin. Some studies suggest that
phytoene and phytofluene may be involved in diverse health-
promoting actions. Thus, phytoene and phytofluene could
act as antioxidants or anti-inflammatory compounds or
protect against cancer and light-induced damage in the
skin. Being naturally present in common and exotic foods,
including ancient wild relatives of the domesticated tomato,
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their intake at dietary levels is not expected to be of safety
concern. However, since their interest in the context of the
diet, functional foods, and nutricosmetics is expanding, it
is important to conduct studies aimed at assessing their
safety.
Thus, we present herein the results of in vitro cytotoxicity
studies (NRR protocol) on phytoene- and phytofluene-rich
extracts from two sources (tomato and Dunaliella salina),
showing that these extracts have negligible cytotoxicity in
this model; by an in vitro genotoxicity study on a phytoene-
and phytofluene-rich extract of Dunaliella salina, showing
no genotoxic potential for this extract in the tested model;
by in vivo (human) 48 h patch tests of three phytoene-
and phytofluene-rich extracts from two sources (tomato
and Dunaliella salina), showing that these extracts have
very good skin compatibility; and by a longer-term Human
Repeat Insult Patch Test of a phytoene- and phytofluene-rich
Dunaliella salina extract, showing that the tested extract did
not induce any skin sensitization and was very well tolerated
on human skin.
The facts that both EFSA and FDA have provided positive
opinions concerning the safety of tomato products and that
these contain phytoene and phytofluene at lower amounts rel-
ative to lycopene but still high, considering the classification
of Britton and Khachik [26, 79], adds support to the safety
of phytoene and phytofluene as food ingredients. The above
data speak strongly in favor of the safe use of phytoene- and
phytofluene-rich products for a variety of human uses. In this
light and that of other data on the safety of other dietary
carotenoids, it would not be surprising that ADIs comparable
to those established for lycopene or lutein could eventually
be established for phytoene and phytofluene, although, of
course, the pertinent toxicological studies will need to be
performed.
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